Jointown Pharmaceutical Group Co., Ltd. (SSE:600998) Filings

Jointown Pharmaceutical Group Co., Ltd.

Filings

FilingDateTypeFiled with
(600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Release of Pledge and Pledge of Shares Held by ShareholdersNov 20, 2026Other filingsShanghai Stock Exchange
(600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Progress in Providing Guarantees for SubsidiariesNov 18, 2026Other filingsShanghai Stock Exchange
(600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Resolutions of the 4th Extraordinary General Meeting in 2026Nov 10, 2026Meeting noticeShanghai Stock Exchange
(600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Resolutions of the 1st Meeting of the 7th Board of DirectorsNov 10, 2026Meeting outcomeShanghai Stock Exchange
(600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Election of Employee Representative Director for the 7th Board of DirectorsNov 3, 2026Management or board changeShanghai Stock Exchange
(600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Provision of Online Voting Reminder Service for General MeetingNov 3, 2026Notification letterShanghai Stock Exchange
(600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Outline of Q3 2026 Performance BriefingNov 3, 2026ResultsShanghai Stock Exchange
(600998)"Jointown Pharmaceutical Group Co., Ltd."Indicative Announcement on the 4th Extraordinary General Meeting in 2026Nov 3, 2026Meeting noticeShanghai Stock Exchange
(600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Issuance Results of the 3rd Tranche of Medium-term Notes for 2026 (Supporting the Elderly Care Industry)Oct 31, 2026FinancingShanghai Stock Exchange
(600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Shareholding Increase by the Chairman, Vice Chairman and General ManagerOct 30, 2026Ownership change noticeShanghai Stock Exchange
(600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Signing of the Strategic Cooperation Agreement with JOINN LABORATORIES (CHINA) CO., LTD. and Other PartiesOct 30, 2026Material contractShanghai Stock Exchange
(600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Obtaining Drug Registration Certificate for Vitamin B6 InjectionOct 29, 2026Operations updateShanghai Stock Exchange
(600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Voluntary Disclosure of Shareholder Rewards EventOct 27, 2026Other filingsShanghai Stock Exchange
(600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Election of New Board of DirectorsOct 24, 2026Management or board changeShanghai Stock Exchange
(600998)"Jointown Pharmaceutical Group Co., Ltd."Pre-announcement on Convening the Q3 2026 Performance BriefingOct 24, 2026Meeting noticeShanghai Stock Exchange
(600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Resolutions of the 25th Meeting of the 6th Board of DirectorsOct 24, 2026Other filingsShanghai Stock Exchange
(600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on the 2026 Interim Dividend Distribution PlanOct 24, 2026DividendShanghai Stock Exchange
(600998)"Jointown Pharmaceutical Group Co., Ltd."Report for Q3 2026Oct 24, 2026Other filingsShanghai Stock Exchange
(600998)"Jointown Pharmaceutical Group Co., Ltd."Notice on Convening the 4th Extraordinary General Meeting in 2026Oct 24, 2026Meeting noticeShanghai Stock Exchange
(600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Progress in Providing Guarantees for SubsidiariesOct 22, 2026Other filingsShanghai Stock Exchange
(600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Completion of Redemption of the 2nd Tranche of Super Short-term Commercial Paper for 2026 (Supporting the Elderly Care Industry)Oct 21, 2026FinancingShanghai Stock Exchange
(600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Completion of Industrial and Commercial Registration Changes and Filing of the Articles of AssociationOct 21, 2026Other filingsShanghai Stock Exchange
(600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Acquisition of Patents in Q3 2026Oct 20, 2026Acquisition or disposalShanghai Stock Exchange
(600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Issuance Results of the 3rd Tranche of Super Short-term Commercial Paper for 2026 (Supporting the Elderly Care Industry)Oct 16, 2026FinancingShanghai Stock Exchange
(600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Entrusted Wealth Management with Temporarily Idle Funds for Q3 2026Oct 14, 2026Other filingsShanghai Stock Exchange
"Jointown Pharmaceutical Group Co., Ltd."Announcement on Release of Pledge and Pledge of Shares by the Controlling Shareholder and Its Person Acting in ConcertSep 28, 2026Other filingsShanghai Stock Exchange
"Jointown Pharmaceutical Group Co., Ltd."Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2026Sep 17, 2026Meeting outcomeShanghai Stock Exchange
"Jointown Pharmaceutical Group Co., Ltd."Announcement on Progress in Providing Guarantees for SubsidiariesSep 11, 2026Operations updateShanghai Stock Exchange
"Jointown Pharmaceutical Group Co., Ltd."Indicative Announcement on Convening the 3rd Extraordinary General Meeting in 2026Sep 9, 2026Meeting noticeShanghai Stock Exchange
"Jointown Pharmaceutical Group Co., Ltd."Announcement on Outline of the 2026 Semi-annual Performance BriefingSep 2, 2026Meeting noticeShanghai Stock Exchange
"Jointown Pharmaceutical Group Co., Ltd."Announcement on Resolutions of the 24th Meeting of the 6th Board of DirectorsAug 31, 2026Other filingsShanghai Stock Exchange
"Jointown Pharmaceutical Group Co., Ltd."Announcement on Winning of a Bid by a Controlled Subsidiary for the County-level Medical Community Information Integration Construction ProjectAug 28, 2026Operations updateShanghai Stock Exchange
"Jointown Pharmaceutical Group Co., Ltd."Announcement on Issuance of the Second Tranche of Asset-backed Commercial Paper for 2026 (Supporting the Elderly Care Industry) and Related Party TransactionsAug 27, 2026FinancingShanghai Stock Exchange
"Jointown Pharmaceutical Group Co., Ltd."Semi-annual Report for 2026Aug 24, 2026Interim reportShanghai Stock Exchange
"Jointown Pharmaceutical Group Co., Ltd."Announcement on Signing of the "Strategic Cooperation Agreement" with Guomin Pension & Insurance Co., Ltd. and Related Party TransactionsAug 21, 2026Material contractShanghai Stock Exchange
"Jointown Pharmaceutical Group Co., Ltd."Announcement on Resolutions of the 22nd Meeting of the 6th Board of DirectorsAug 20, 2026Meeting outcomeShanghai Stock Exchange
"Jointown Pharmaceutical Group Co., Ltd."Announcement on Provision of Online Voting Reminder Service for General MeetingAug 14, 2026Notification letterShanghai Stock Exchange
"Jointown Pharmaceutical Group Co., Ltd."Announcement on Acquisition of the Compliance Management System Certification CertificateAug 4, 2026Compliance certificateShanghai Stock Exchange
"Jointown Pharmaceutical Group Co., Ltd."Announcement on Election of Directors, Appointment of Senior Management and Resignation of DirectorsJul 28, 2026Management or board changeShanghai Stock Exchange
"Jointown Pharmaceutical Group Co., Ltd."Announcement on Early Release of Pledge and Pledge of Shares by the Controlling Shareholder and Its Persons Acting in ConcertJul 24, 2026Other filingsShanghai Stock Exchange
"Jointown Pharmaceutical Group Co., Ltd."Announcement on Completion of Redemption of the First Tranche of Sci-Tech Innovation Bonds in 2026Jul 20, 2026FinancingShanghai Stock Exchange
"Jointown Pharmaceutical Group Co., Ltd."Announcement on Inclusion of Products of Subsidiaries in the "National Essential Medicines List (2026 Edition)"Jul 15, 2026Operations updateShanghai Stock Exchange
"Jointown Pharmaceutical Group Co., Ltd."Announcement on Progress in Providing Guarantee for SubsidiaryJul 10, 2026Other filingsShanghai Stock Exchange
"Jointown Pharmaceutical Group Co., Ltd."Announcement on Entrusted Wealth Management of Temporarily Idle Funds for Q2 2026Jul 6, 2026Other filingsShanghai Stock Exchange
"Jointown Pharmaceutical Group Co., Ltd."Announcement on Attending the 2026 Collective Reception Day for Investors of Listed Companies in Hubei JurisdictionJul 1, 2026Other filingsShanghai Stock Exchange
Announcement on Resolutions of the 20th Meeting of the 6th Board of DirectorsJun 26, 2026Meeting outcomeShanghai Stock Exchange
Announcement on Release and Pledge of Shares by the Controlling Shareholder and Its Persons Acting in ConcertJun 23, 2026Other filingsShanghai Stock Exchange
Announcement on Progress in Providing Guarantee for SubsidiaryJun 16, 2026Other filingsShanghai Stock Exchange
Announcement on Issuance of the Phase I Asset-backed Notes for 2026 and Related Party TransactionsJun 10, 2026FinancingShanghai Stock Exchange
Announcement on Subsidiary Obtaining Approval for Marketing of Chemical APIsJun 2, 2026Operations updateShanghai Stock Exchange
Announcement on Implementation of Dividend Distribution for 2025Jun 1, 2026DividendShanghai Stock Exchange
Announcement on Subsidiary's Drug Passing Generic Drug Consistency EvaluationMay 26, 2026Operations updateShanghai Stock Exchange
Announcement on Resolutions of the 2025 Annual General MeetingMay 21, 2026Meeting noticeShanghai Stock Exchange
Indicative Announcement on Convening the 2025 Annual General MeetingMay 14, 2026Meeting noticeShanghai Stock Exchange
Announcement on Recognition of Subsidiary as High-tech EnterpriseMay 12, 2026Other filingsShanghai Stock Exchange
Announcement on Subsidiary's Passing GMP Compliance Inspection for DrugsMay 6, 2026Operations updateShanghai Stock Exchange
Announcement on Holding Subsidiary Certified as High-tech EnterpriseApr 29, 2026Other filingsShanghai Stock Exchange
Report for Q1 2026Apr 27, 2026Quarterly reportShanghai Stock Exchange
Announcement on Results of Issuing Phase II Ultra-Short-Term Financing Bonds of 2026Apr 23, 2026FinancingShanghai Stock Exchange
Announcement on the Subsidiary Receiving the "Acceptance Notice" from the National Medical Products Administration for the Market Application of Azelastine Hydrochloride Nasal SprayApr 21, 2026Operations updateShanghai Stock Exchange
Announcement on Temporary Idle Funds’ Investment Management Arrangements for Q1 2026Apr 8, 2026Other filingsShanghai Stock Exchange
Announcement on Receipt of the "Notice of Registration Acceptance" from the National Association of Financial Market Institutional InvestorsApr 2, 2026FinancingShanghai Stock Exchange
Announcement on Obtaining Medical Device Registration Certificate by Holding SubsidiaryMar 24, 2026Other filingsShanghai Stock Exchange
Announcement on the Results of Issuance of the 2026 Phase II Science and Technology Innovation BondsMar 11, 2026Other filingsShanghai Stock Exchange
Announcement on Advance Release and Pledge of Shares by the Controlling Shareholder and Its Persons Acting in ConcertFeb 10, 2026Other filingsShanghai Stock Exchange
Announcement on the Subsidiary Receiving the "Acceptance Notice" from the National Medical Products Administration for the Market Application of Betahistine Hydrochloride TabletsFeb 6, 2026Operations updateShanghai Stock Exchange
Announcement on Completion of Industrial and Commercial Change Registration and Filing of Articles of AssociationJan 22, 2026Other filingsShanghai Stock Exchange
Announcement on the Results of Issuance of the 2026 Phase I Science and Technology Innovation BondsJan 21, 2026FinancingShanghai Stock Exchange
Announcement on Entrusted Financial Management in Q4 2025Jan 16, 2026Other filingsShanghai Stock Exchange
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026Jan 7, 2026Meeting noticeShanghai Stock Exchange
Announcement on Obtaining Drug Registration Certificate for Bupivacaine Hydrochloride InjectionJan 6, 2026Operations updateShanghai Stock Exchange
Announcement on Provision of Online Voting Reminder Service for General MeetingJan 4, 2026Meeting noticeShanghai Stock Exchange
Announcement on Early Release of Pledge and Pledge of Shareholders' SharesDec 30, 2025Other filingsShanghai Stock Exchange
Announcement on Completion of Execution of Reorganization Plan of Aoyuan Beauty Valley Technology Co., Ltd., in Which the Wholly-owned Subsidiary Participated as a Reorganization InvestorDec 29, 2025Operations updateShanghai Stock Exchange
Announcement on Obtaining Drug Registration Certificate for Isopropylamine Hydrochloride InjectionDec 26, 2025Other filingsShanghai Stock Exchange
Indicative Announcement Completion of the Redemption and Delisting of the 2022 Non-Convertible Corporate Bonds (Phase III) by the Controlling Shareholder, and the Intention to Handle the Release of Stock Pledge and Trust RegistrationDec 23, 2025Other filingsShanghai Stock Exchange
Notice on Convening the 1st Extraordinary General Meeting in 2026Dec 19, 2025Meeting noticeShanghai Stock Exchange
Indicative Announcement Completion of the Redemption and Delisting of the 2022 Non-Convertible Corporate Bonds (Phase II) by the Controlling Shareholder, and the Intention to Handle the Release of Stock Pledge and Trust RegistrationDec 17, 2025Other filingsShanghai Stock Exchange
Announcement on Issuance of the Phase I Asset-backed Notes for 2025 and Related Party TransactionsNov 21, 2025FinancingShanghai Stock Exchange
Announcement on Progress in Court's Acceptance of the Reorganization and Appointment of a Administrator for Aoyuan Meigu Technology Co., Ltd., a Wholly-owned Subsidiary Participating in the Reorganization InvestmentNov 16, 2025Legal or regulatory actionShanghai Stock Exchange
Announcement on Pledge of Shareholders' SharesNov 13, 2025Other filingsShanghai Stock Exchange
Announcement on Completion of Filing for Industrial Fund Established by Holding Grandchild SubsidiaryNov 11, 2025Other filingsShanghai Stock Exchange
Announcement on Outline of the Q3 2025 Performance BriefingNov 4, 2025Other filingsShanghai Stock Exchange
Announcement on Resolutions of the 17th Meeting of the 6th Board of DirectorsOct 27, 2025Other filingsShanghai Stock Exchange
Announcement on Entrusted Financial Management in Q3 2025Oct 14, 2025Other filingsShanghai Stock Exchange
Indicative Announcement Completion of the Redemption and Delisting of the 2022 Non-Convertible Corporate Bonds (Phase I) by the Controlling Shareholder, and the Intention to Handle the Release of Stock Pledge and Trust RegistrationOct 10, 2025Other filingsShanghai Stock Exchange
Announcement on Early Release of Pledge of Shareholders' SharesSep 26, 2025Other filingsShanghai Stock Exchange
Announcement on Participating in the Establishment of Industrial Fund and Related Party TransactionsSep 22, 2025Other filingsShanghai Stock Exchange
Announcement on Outline of the 2025 Semi-annual Performance BriefingSep 3, 2025Other filingsShanghai Stock Exchange
Announcement on Resolutions of the 16th Meeting of the 6th Board of DirectorsAug 26, 2025Other filingsShanghai Stock Exchange
Announcement on Upgrading Subject Credit Rating to AAAAug 25, 2025Other filingsShanghai Stock Exchange
Announcement on Expiration of Duration and Termination of Phase III Employee Stock Ownership Plan in 2022Jul 21, 2025Other filingsShanghai Stock Exchange
Announcement on Entrusted Financial Management in Q2 2025Jul 16, 2025Other filingsShanghai Stock Exchange
Announcement on the Completion of Filing for the Industry Fund Established by Wholly-Owned SubsidiaryJul 4, 2025Other filingsShanghai Stock Exchange
Announcement on Obtaining Drug Registration Certificate for Dexamethasone Sodium Phosphate InjectionJun 20, 2025Other filingsShanghai Stock Exchange